The hallmarks of castration-resistant prostate cancers
Katsogiannou, Maria, Ziouziou, Hajer, Karaki, Sara, Andrieu, Claudia, Henry de Villeneuve, Marie, Rocchi, Palma
Published in Cancer treatment reviews (01.07.2015)
Published in Cancer treatment reviews (01.07.2015)
Get full text
Journal Article
Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
Ziouziou, Hajer, Andrieu, Claudia, Laurini, Erik, Karaki, Sara, Fermeglia, Maurizio, Oueslati, Ridha, Taieb, David, Camplo, Michel, Siri, Olivier, Pricl, Sabrina, Katsogiannou, Maria, Rocchi, Palma
Published in Oncotarget (29.09.2017)
Published in Oncotarget (29.09.2017)
Get full text
Journal Article
Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer
Ziouziou, Hajer, Paris, Clément, Benizri, Sébastien, Le, Thi Khanh, Andrieu, Claudia, Nguyen, Dang Tan, Appavoo, Ananda, Taïeb, David, Brunel, Frédéric, Oueslati, Ridha, Siri, Olivier, Camplo, Michel, Barthélémy, Philippe, Rocchi, Palma
Published in Pharmaceutics (27.04.2021)
Published in Pharmaceutics (27.04.2021)
Get full text
Journal Article
Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
Ziouziou, Hajer, Andrieu, Claudia, Laurini, Erik, Karaki, Sara, Fermeglia, Maurizio, Oueslati, Ridha, Taieb, David, Camplo, Michel, Siri, Olivier, Pricl, Sabrina, Katsogiannou, Maria, Rocchi, Palma
Published in Oncotarget (19.06.2018)
Published in Oncotarget (19.06.2018)
Get full text
Journal Article